M20-466
Brief Summary:
This study is a randomized, double-blinded study to evaluate the safety and efficacy of ABBV-154 in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to Biologic and/or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs.
View The Patient Letter For This Study